| Metric | Q3 2026 | Q2 2026 | Q3 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $2.5B | — | — | — | — |
| Op. Income | $374M | — | — | — | — |
| Gross Margin | 29.0% | — | — | — | — |
| Net Margin | 13.2% | — | — | — | — |
| EPS (Diluted) | $0.03 | — | — | — | — |
| Free Cash Flow | $403M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $2.5B |
| Cost of Revenue | $1.8B |
| GROSS PROFIT | $732M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $358M |
| Other Expenses | $0 |
| Operating Expenses | $358M |
| Cost & Expenses | $2.1B |
| OPERATING INCOME | $374M |
| Interest Income | $99M |
| Interest Expense | $39M |
| Other Income/Expenses | $68M |
| INCOME BEFORE TAX | $443M |
| Income Tax Expense | $106M |
| Net Income from Continuing Ops | $337M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $334M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $334M |
| D&A | $0 |
| EBIT | $481M |
| EBITDA | $481M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $2.5B |
| Cost of Revenue | $1.8B |
| GROSS PROFIT | $732M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $358M |
| Other Expenses | $0 |
| Operating Expenses | $358M |
| Cost & Expenses | $2.1B |
| OPERATING INCOME | $374M |
| Interest Income | $99M |
| Interest Expense | $39M |
| Other Income/Expenses | $68M |
| INCOME BEFORE TAX | $443M |
| Income Tax Expense | $106M |
| Net Income from Continuing Ops | $337M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $334M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $334M |
| D&A | $0 |
| EBIT | $481M |
| EBITDA | $481M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $334M |
| Depreciation & Amortization | $85M |
| Stock-Based Compensation | $14M |
| Deferred Income Tax | $105M |
| Other Non-Cash Items | -$157M |
| Change in Working Capital | $70M |
| OPERATING CASH FLOW | $452M |
| Capital Expenditure | -$50M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$1.8B |
| Sales/Maturities of Investments | $1.2B |
| Other Investing Activities | -$219M |
| NET CASH FROM INVESTING | -$865M |
| Net Debt Issuance | $292M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$16M |
| NET CASH FROM FINANCING | $276M |
| FREE CASH FLOW | $403M |
| Net Change in Cash | -$127M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.3B |
| Short-Term Investments | $4.8B |
| Net Receivables | $2.4B |
| Inventory | $8M |
| Other Current Assets | $430M |
| TOTAL CURRENT ASSETS | $9.0B |
| PP&E (Net) | $1.2B |
| Goodwill | $3.9B |
| Intangible Assets | $313M |
| Long-Term Investments | $406M |
| Tax Assets | $47M |
| Other Non-Current Assets | $174M |
| TOTAL NON-CURRENT ASSETS | $6.0B |
| TOTAL ASSETS | $15.0B |
| Account Payables | $1.1B |
| Short-Term Debt | $1.8B |
| Deferred Revenue | $275M |
| Other Current Liabilities | $495M |
| TOTAL CURRENT LIABILITIES | $4.1B |
| Long-Term Debt | $20M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $189M |
| Other Non-Current Liabilities | $844M |
| TOTAL NON-CURRENT LIABILITIES | $1.3B |
| TOTAL LIABILITIES | $5.4B |
| Common Stock | $223M |
| Additional Paid-In Capital | $62M |
| Retained Earnings | $8.1B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $861M |
| Other Equity | $302M |
| TOTAL STOCKHOLDERS' EQUITY | $9.5B |
| Minority Interest | $23M |
| TOTAL EQUITY | $9.5B |
| TOTAL LIABILITIES & EQUITY | $15.0B |
| Total Debt | $2.1B |
| Net Debt | $840M |
